Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06893276 · ClinicalTrials.gov registry record · NA
e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
A NA study, sponsored by University of Miami.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06893276: Clinical Trial NA study, sponsored by University of Miami.
NCT06893276 is a NA study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06893276, a NA study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.
Primary Outcome
Will be measured in percentages (%). The study will be considered feasible passed 60%.
Interventions
- BEHAVIORAL ePSMI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2026-11-27 |
| Phase | NA |
What is known before NCT06893276 opens enrollment
NCT06893276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which ePSMI is the first listed.
NCT06893276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06893276 about?
NCT06893276 is a clinical study titled "e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients". The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.
What is the current status of trial NCT06893276?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-08-01. Estimated completion is 2026-11-27.
What interventions are being tested in trial NCT06893276?
The interventions under investigation include: ePSMI (BEHAVIORAL).
Who is sponsoring clinical trial NCT06893276?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06893276's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI